Androgen suppression therapy and prostate cancer: balancing the harms and the benefits.
Oefelein
Michael G
MG
D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D018426:SEER Program
D000726:Androgen Antagonists